23/08/2021
Published by Wp_Admin at 23/08/2021
Categories

Anti-PD-1 therapy, evaluating tumor-specific MHC-II expression to predict clinical benefits

Do you like it?0
Read more
05/07/2021
Published by Wp_Admin at 05/07/2021
Categories

Cancers of unknown origin, hope from MEK inhibitors

Do you like it?0
Read more
28/06/2021
Published by Wp_Admin at 28/06/2021
Categories

Advanced urothelial cancer: questionable efficacy of durvalumab in combination with different targeted drugs

Do you like it?0
Read more